We are live on ! Find out more
AEMD icon

Aethlon Medical
AEMD

14 hedge funds and large institutions have $389K invested in Aethlon Medical in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

17% more funds holding

Funds holding: 12 → 14 (+2)

0.09% more ownership

Funds ownership: 0.31% → 0.4% (+0.09%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

19% less capital invested

Capital invested by funds: $481K → $389K (-$92K)

Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
1
Reduced
1
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
+$151K
2
Citadel Advisors
Citadel Advisors
Florida
+$110K
3
Renaissance Technologies
Renaissance Technologies
New York
+$53K
4
SRL
Scientech Research LLC
New Jersey
+$30K
5
Two Sigma Investments
Two Sigma Investments
New York
+$23.3K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$222K
2
BFM
Boothbay Fund Management
New York
-$53.8K
3
UBS Group
UBS Group
Switzerland
-$1.96K
4
BlackRock
BlackRock
New York
-$922
5
Morgan Stanley
Morgan Stanley
New York
-$346
Name Holding Trade Value Shares
Change 		Change in
Stake
IC
1
Ikarian Capital
Texas
$115K – – –
HF
2
HRT Financial
New York
$97K +$151K +2,612 New
Citadel Advisors
3
Citadel Advisors
Florida
$71.2K +$110K +1,902 New
Renaissance Technologies
4
Renaissance Technologies
New York
$34.4K +$53K +920 New
SRL
5
Scientech Research LLC
New Jersey
$19.5K +$30K +520 New
Two Sigma Investments
6
Two Sigma Investments
New York
$15.2K +$23.3K +405 New
XT
7
XTX Topco
Cayman Islands
$11.6K +$17.9K +310 New
TSS
8
Two Sigma Securities
New York
$11K +$16.9K +294 New
Geode Capital Management
9
Geode Capital Management
Massachusetts
$10.1K – – –
TRCT
10
Tower Research Capital (TRC)
New York
$2.24K +$2.65K +46 +329%
Citigroup
11
Citigroup
New York
$1.84K +$2.82K +49 New
Group One Trading
12
Group One Trading
Illinois
$113 – – –
BlackRock
13
BlackRock
New York
$71 -$922 -16 -89%
Wells Fargo
14
Wells Fargo
California
$19 – – –
Bank of America
15
Bank of America
North Carolina
$16 -$58 -1 Closed
Osaic Holdings
16
Osaic Holdings
Arizona
$12 – – –
Morgan Stanley
17
Morgan Stanley
New York
$7 -$346 -6 Closed
BCWM
18
Bartlett & Co Wealth Management
Ohio
$2 – – –
DB
19
Danske Bank
Denmark
$2 – – –
SS
20
SBI Securities
Japan
$1 – – –
AC
21
Armistice Capital
New York
– -$222K -3,700 Closed
BFM
22
Boothbay Fund Management
New York
– -$53.8K -897 Closed
UBS Group
23
UBS Group
Switzerland
– -$1.96K -33 Closed
Raymond James Financial
24
Raymond James Financial
Florida
– -$340 -6 Closed
Fidelity Investments
25
Fidelity Investments
Massachusetts
– -$12 – –

AEMD Hedge Fund Activity: Q3 2025 in Review

14 of the 7,625 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q3 2025, worth a combined $389K — down 19% from $481K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new AEMD positions and 6 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was HRT Financial, opening a new position worth an estimated $151K. The largest seller was Armistice Capital, exiting entirely with an estimated $222K sold.

  • 14 institutional investors held Aethlon Medical (AEMD) as of Q3 2025, up from 12 in Q2 2025.
  • Funds reported $389K of Aethlon Medical stock for Q3 2025, down 19% quarter-over-quarter.
  • 8 funds opened new Aethlon Medical positions in Q3 2025 and 6 closed out, a net change of +2 holders.
  • The largest Aethlon Medical buyer in Q3 2025 was HRT Financial, an estimated $151K added.
  • The largest Aethlon Medical seller in Q3 2025 was Armistice Capital, an estimated $222K sold.

Based on aggregated 13F filings for Q3 2025.